Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
440 studies found for:    "Thyroid Neoplasms"
Show Display Options
Rank Status Study
1 Recruiting An Observational Study in Differentiated Thyroid Cancer Which is Radioactive Iodine (RAI) Refractory to Assess the Use of Multikinase Inhibitors
Condition: Thyroid Neoplasms
Interventions: Drug: Sorafenib (Nexavar, BAY43-9006);   Drug: Other Multikinase inhibitors
2 Completed Phase II Study of IMRT With SIB as Adjuvant Treatment for High Risk Resected Well-differentiated Thyroid Cancer.
Condition: Thyroid Neoplasms
Intervention: Procedure: IMRT
3 Recruiting Minimize Radioactive Iodine Ablation Of Remnant Thyroid in Differentiated Thyroid Cancer
Condition: Thyroid Neoplasms
Interventions: Drug: I-131;   Drug: I-125
4 Completed A Phase II Trial of Valproic Acid in Patients With Advanced Thyroid Cancers of Follicular Cell Origin
Condition: Thyroid Neoplasm
Interventions: Drug: Valproic Acid;   Drug: Liothyronine Sodium
5 Recruiting Institut Paoli Calmettes Thyroid Cancer Database
Condition: Thyroid Neoplasms
Intervention: Other: Data collection
6 Recruiting Post-marketing Surveillance of Lenvatinib Mesylate (Lenvima Capsule) in Patients With Unresectable Thyroid Cancer (Study LEN01T)
Condition: Thyroid Neoplasms
Intervention: Drug: Lenvatinib
7 Completed P53 in Differentiated Thyroid Cancer
Condition: Thyroid Neoplasms
Intervention:
8 Completed Multicenter Study Differentiated Thyroid Carcinoma
Condition: Thyroid Neoplasms
Intervention: Procedure: external beam radiotherapy
9 Completed
Has Results
Study Of AG-013736 In Patients With 131I-Refractory Thyroid Cancer
Condition: Thyroid Neoplasms
Intervention: Drug: AG-013736
10 Recruiting Assessment of Quality of Life After Adjunct Radioiodine Therapy in Patients With Differentiated Thyroid Cancer
Condition: Thyroid Neoplasms
Intervention:
11 Completed
Has Results
Study of the Anti-angiogenesis Agent AG-013736 in Patients With Metastatic Thyroid Cancer
Condition: Thyroid Neoplasms
Intervention: Drug: AG013736
12 Unknown  A Prospective Phase I Study of Cyclotron-produced Tc-99m Pertechnetate (CPERT) in Patients With Thyroid Cancer
Condition: Thyroid Neoplasms
Interventions: Drug: CPERT;   Drug: GPERT
13 Active, not recruiting
Has Results
Nexavar® Versus Placebo in Locally Advanced/Metastatic RAI-Refractory Differentiated Thyroid Cancer
Condition: Thyroid Neoplasms
Interventions: Drug: Sorafenib (Nexavar, BAY43-9006);   Drug: Placebo
14 Completed Phase II Two-step Radioimmunotherapy Clinical Study in Medullary Thyroid Carcinoma
Condition: Thyroid Neoplasms
Intervention: Drug: bispecific antibody and di-DTPA-131I
15 Active, not recruiting
Has Results
Efficacy and Safety of Vandetanib (ZD6474) in Patients With Metastatic Papillary or Follicular Thyroid Cancer
Condition: Thyroid Neoplasms
Interventions: Drug: Vandetanib;   Other: Placebo
16 Unknown  PET Evaluation of Recurrent Differentiated Thyroid Cancer
Conditions: Thyroid Neoplasms;   Differentiated Thyroid Cancer
Intervention:
17 Completed Clinical Evaluation of a New Highly Sensitive Thyroglobulin Assay in Differentiated Thyroid Carcinoma
Condition: Thyroid Neoplasms
Intervention:
18 Terminated
Has Results
Ponatinib for Advanced Medullary Thyroid Cancer
Condition: Thyroid Neoplasms
Intervention: Drug: Ponatinib
19 Active, not recruiting REVLIMID® (Lenalidomide) for Therapy of Radioiodine-Unresponsive Papillary and Follicular Thyroid Carcinomas
Condition: Thyroid Neoplasms
Intervention: Drug: Lenalidomide
20 Recruiting Safety and Efficacy of Sorafenib in Patients With Advanced Thyroid Cancer: a Phase II Clinical Study
Condition: Thyroid Cancer
Intervention: Drug: Sorafenib

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.